What is CAGR? What does CAGR table indicate for Welcure Drugs & Pharmaceuticals Ltd?

Compounded average growth rate (CAGR) measures the average annual growth rate compounded year-on-year over a period of time.

Welcure Drugs & Pharmaceuticals Ltd Stock Analysis

Q: Is Welcure Drugs & Pharmaceuticals Ltd a good quality company?

MoneyWorks4Me analysed the past 10-year performance of Welcure Drugs & Pharmaceuticals Ltd and arrived at the following conclusion.

Small Cap

Evaluated by 137 users | BSE: 524661 | NSE: |
Trading

Welcure Drugs & Pharmaceuticals Ltd. (WDPL) was incorporated as a Public Limited Company under the Companies Act, 1956 on 4th June, 1992 and obtained the certificate of commencement of business on 19th June 1992. Welcure is an Internationally ISO 9001:2000 and WHO-GMP Certified...

10 Year X-Ray

Standalone basis Standalone basis P Consolidated basis

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

What is a Financial Track Record? How to read this chart in order to understand the data present here?

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Return on Capital Employed	35.31%	231.61%	-14.4%	-3.67%	-7.67%	-274.47%	108.82%	-65.56%	18.1%	-49.36%

Growth Parameters	Growth Parameters Colour Code Guide

Net Sales (Rs. Cr.)	0.9	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1
Y-o-Y Gr. Rt.	-	-100%	NA	33.3%	25%	100%	-10%	-44.4%	60%	0%
Adjusted EPS (Rs.)	0.23	-0.08	0.01	0	0	0.06	0.02	-0.01	0	-0.01
Y-o-Y Gr. Rt.	-	-134.8%	NA	-100%	NA	NA	-66.7%	-150%	NA	NA
Book Value per Share (Rs.)	0.01	-0.08	-0.07	-0.07	-0.06	0.01	0.03	0.02	0.02	0.01
Adjusted Net Profit	0.3	-0.1	0	0	0	0.1	0	0	0	0
Net Op. Cash Flow (Rs. Cr.)	-2.9	-0.2	0	0	0	-0.1	0	0	0	0
Debt to Cash Flow from Ops	0	0	0	0	0	0	0	0	0	0

Difference between Standalone Basis and Consolidated basis? Which method is preferred for Welcure Drugs & Pharmaceuticals Ltd. ?

Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.

Welcure Drugs & Pharmaceuticals Ltd. should be analysed on a Standalone basis

CAGR CAGR Colour Code Guide

	9 yrs	5 yrs	3 yrs	1 yr
Net Sales	-23.3%	9.9%	-3.9%	0
Adjusted EPS	-170.6%	NA	-179.4%	NA
Book Value per Share	0	0	-30.7	-50
Share Price	4.2%	-4.7%	14.2%	452.6%

Key Financial Parameter	Performance Ratio Colour Code Guide

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Return on Equity (%)	-45.99	232.28	-14.37	-3.62	-7.64	-274.33	108.61	-65.8	17.83	-49.66
Operating Profit Margin (%)	-67.29	0	-25.25	-27.09	6.9	32.43	30.86	-41	2.91	-11.76
Net Profit Margin (%)	35.38	0	39.48	7.81	11.58	85.59	30.77	-38.8	4.88	-11.43
Debt to Equity	0	0	0	0	0	0	0	0	0	0
Working Capital Days	488	0	25	53	45	28	60	109	59	76
Cash Conversion Cycle	-224	0	0	0	0	0	0	0	0	0

Management X-Ray

Shareholding Pattern

Entity	Percentage Holding
Promoters	14.12%
Institutions	0.01%
Non-Institutions	85.86%

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

FAQs

1. Is Welcure Drugs & Pharmaceuticals Ltd a good quality company?

Data is not available for this company.

2. Is current market price of Welcure Drugs & Pharmaceuticals Ltd a good price to buy it?

The 5-year analysis of Welcure Drugs & Pharmaceuticals Ltd's performance infers:

Welcure Drugs & Pharmaceuticals Ltd earnings have grown by 0%, whereas share price has depreciated -4.7% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

3. What is Welcure Drugs & Pharmaceuticals Ltd share price return in the past 10 years ?

We analysed the performance of Welcure Drugs & Pharmaceuticals Ltd share prices over the last 10 years. Here is what we found out:

Welcure Drugs & Pharmaceuticals Ltd share price has depreciated 2.3% annually over the past ten years.

About Company

Welcure is an Internationally ISO 9001:2000 and WHO-GMP Certified Company. It has to its credit the most modern and sophisticated manufacturing facilities of International Standards which include ultramodern plant, machinery and equipment, own R & D, in house

Presently, the Company is engaged in the business of manufacture and marketing of pharmaceuticals formulations in the form of tablets, capsules and dry syrups. The Company is manufacturing over hundred varieties of formulations including antibiotics, sulpha drugs, vitamins, analgesics, antipyretics, corticosteroids, anti-malarials, anti-dysentery, anti-tuberculosis, anti-diabetics, tranquilisers, sedatives and gastro intestinals. The products of the company have already been well accepted in the domestic markets and the Company has an established customer base.

In March 2000 WDPL entered into a five-year agreement with Bihar Drugs and Chemicals Ltd (BDCL), a subsidiary of Bihar State Pharmaceutical and Chemical Development Corporation Ltd, for manufacturing various pharmaceutical pro ducts (both generic as well as branded) for the latter on loan licence basis. WDPL manufactures the drugs in tablet, capsule and syrup form at its facilities situated in Bhiwadi (Rajasthan).

The Companyâ€™s principal activity is to manufacture pharmaceutical products. The products of the Company include tablets, capsules, liquid orals and dry syrups.

Product range of the company includes:

Welcure manufactures a large variety of pharmaceutical formulations, covering almost all ailments, about 250 in numbers. Some of our known products include: